Gabapentin
- Product NDC
- 33261-051
- 11-digit product format
- 332610051
- Labeler code
- 33261
- Product ID
- 33261-051_0756b645-0741-4473-b777-7ee472358140
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aidarex Pharmaceuticals LLC
- Application
- ANDA200651
- Marketing category
- ANDA
- Marketing start
- 2011-10-06
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 33261-051-00 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03ac-f424-e053-dadaa90a57ce | Gabapentin Tablets, USP |
| 33261-051-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03ac-f424-e053-dadaa90a57ce | Gabapentin Tablets, USP |
| 33261-051-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03ac-f424-e053-dadaa90a57ce | Gabapentin Tablets, USP |
| 33261-051-20 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03ac-f424-e053-dadaa90a57ce | Gabapentin Tablets, USP |
| 33261-051-21 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03ac-f424-e053-dadaa90a57ce | Gabapentin Tablets, USP |
| 33261-051-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03ac-f424-e053-dadaa90a57ce | Gabapentin Tablets, USP |
| 33261-051-42 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03ac-f424-e053-dadaa90a57ce | Gabapentin Tablets, USP |
| 33261-051-45 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03ac-f424-e053-dadaa90a57ce | Gabapentin Tablets, USP |
| 33261-051-60 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03ac-f424-e053-dadaa90a57ce | Gabapentin Tablets, USP |
| 33261-051-81 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03ac-f424-e053-dadaa90a57ce | Gabapentin Tablets, USP |
| 33261-051-90 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03ac-f424-e053-dadaa90a57ce | Gabapentin Tablets, USP |
| 33261-051-97 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03ac-f424-e053-dadaa90a57ce | Gabapentin Tablets, USP |
| 33261-051-99 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03ac-f424-e053-dadaa90a57ce | Gabapentin Tablets, USP |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 33261-051-00 | Gabapentin | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | | 3 |
| 33261-051-02 | Gabapentin | 120 in 1 BOTTLE | TABLET, FILM COATED | 120 | | 3 |
| 33261-051-10 | Gabapentin | 10 in 1 BOTTLE | TABLET, FILM COATED | 10 | | 3 |
| 33261-051-20 | Gabapentin | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | | 3 |
| 33261-051-21 | Gabapentin | 21 in 1 BOTTLE | TABLET, FILM COATED | 21 | | 3 |
| 33261-051-30 | Gabapentin | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 3 |
| 33261-051-42 | Gabapentin | 42 in 1 BOTTLE | TABLET, FILM COATED | 42 | | 3 |
| 33261-051-45 | Gabapentin | 45 in 1 BOTTLE | TABLET, FILM COATED | 45 | | 3 |
| 33261-051-60 | Gabapentin | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 3 |
| 33261-051-81 | Gabapentin | 81 in 1 BOTTLE | TABLET, FILM COATED | 81 | | 3 |
| 33261-051-90 | Gabapentin | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 3 |
| 33261-051-97 | Gabapentin | 126 in 1 BOTTLE | TABLET, FILM COATED | 126 | | 3 |
| 33261-051-99 | Gabapentin | 180 in 1 BOTTLE | TABLET, FILM COATED | 180 | | 3 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| GABAPENTIN | ACTIVE INGREDIENT | 6CW7F3G59X | GABAPENTIN TABLET, FILM COATED [AIDAREX PHARMACEUTICALS LLC] | 3 | |
| GABAPENTIN | ACTIVE MOIETY | 6CW7F3G59X | GABAPENTIN TABLET, FILM COATED [AIDAREX PHARMACEUTICALS LLC] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | GABAPENTIN TABLET, FILM COATED [AIDAREX PHARMACEUTICALS LLC] | 3 | |
| COPOVIDONE K25-31 | INACTIVE INGREDIENT | D9C330MD8B | GABAPENTIN TABLET, FILM COATED [AIDAREX PHARMACEUTICALS LLC] | 3 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | GABAPENTIN TABLET, FILM COATED [AIDAREX PHARMACEUTICALS LLC] | 3 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | GABAPENTIN TABLET, FILM COATED [AIDAREX PHARMACEUTICALS LLC] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | GABAPENTIN TABLET, FILM COATED [AIDAREX PHARMACEUTICALS LLC] | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | GABAPENTIN TABLET, FILM COATED [AIDAREX PHARMACEUTICALS LLC] | 3 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | GABAPENTIN TABLET, FILM COATED [AIDAREX PHARMACEUTICALS LLC] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 33261-051 | GABAPENTIN TABLET, FILM COATED [AIDAREX PHARMACEUTICALS LLC] | 3 | Legacy NDC, 13 package rows | 20120927_41f1e929-7c1f-4b3e-b142-4b7533300ee2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 33261-051-00 | 33261005100 | 100 in 1 BOTTLE | Historical |
| 33261-051-02 | 33261005102 | 120 in 1 BOTTLE | Historical |
| 33261-051-10 | 33261005110 | 10 in 1 BOTTLE | Historical |
| 33261-051-20 | 33261005120 | 20 in 1 BOTTLE | Historical |
| 33261-051-21 | 33261005121 | 21 in 1 BOTTLE | Historical |
| 33261-051-30 | 33261005130 | 30 in 1 BOTTLE | Historical |
| 33261-051-42 | 33261005142 | 42 in 1 BOTTLE | Historical |
| 33261-051-45 | 33261005145 | 45 in 1 BOTTLE | Historical |
| 33261-051-60 | 33261005160 | 60 in 1 BOTTLE | Historical |
| 33261-051-81 | 33261005181 | 81 in 1 BOTTLE | Historical |
| 33261-051-90 | 33261005190 | 90 in 1 BOTTLE | Historical |
| 33261-051-97 | 33261005197 | 126 in 1 BOTTLE | Historical |
| 33261-051-99 | 33261005199 | 180 in 1 BOTTLE | Historical |